Aspect Analytics
Founded 2018 · 6 known investors
Aspect Analytics develops Weave, software that aligns and analyzes spatial and molecular data (spatial transcriptomics, proteomics, metabolomics, mass spectrometry imaging, and histology) at single-cell precision to study cellular neighborhoods and tissue architecture. It serves pharma companies, CROs, and research institutes to support drug discovery and development through reproducible, AI-ready spatial biology workflows.
AI & Machine LearningBiotechSaaS
Investors · 6
Also in the syndicate · 3
Capricorn PartnersleadGemma Frisius FundKU Leuven
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ASep 2025
Capricorn Partners (lead), PMV (lead), Gemma Frisius Fund, Heran Partners, KU Leuven
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Aspect Analytics do?
- Aspect Analytics develops Weave, software that aligns and analyzes spatial and molecular data (spatial transcriptomics, proteomics, metabolomics, mass spectrometry imaging, and histology) at single-cell precision to study cellular neighborhoods and tissue architecture. It serves pharma companies, CROs, and research institutes to support drug discovery and development through reproducible, AI-ready spatial biology workflows.
- Who are Aspect Analytics's investors?
- Aspect Analytics's investors include Capricorn Venture Partners, Heran Partners, PMV.